UK markets close in 4 hours 20 minutes

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.34000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1120
Avg. Estimate0.02-0.02-0.260
Low estimate0.02-0.02-0.410
High estimate0.02-0.02-0.110
Year ago EPS-0.08-0.030.14-0.26
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1121
Avg. Estimate500k500k1.3MN/A
Low estimate500k500k600kN/A
High estimate500k500k2MN/A
Year ago sales750k674k1.34M1.3M
Sales growth (year/est)-33.30%-25.80%-3.00%N/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.26-0.1-0.08-0.12
Actual EPS-0.08-0.03-0.080.33
Difference0.180.0700.45
Surprise %69.20%70.00%0.00%375.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.02-0.02-0.260
7 days ago0.02-0.02-0.26-1.08
30 days ago0.02-0.02-0.26-1.08
60 days ago0.02-0.02-0.26-1.08
90 days ago0.02-0.02-0.26-1.08
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesORMPIndustrySector(s)S&P 500
Current qtr.125.00%N/AN/AN/A
Next qtr.33.30%N/AN/AN/A
Current year-285.70%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A